{
    "type": "VariantTherapeuticResponseProposition",
    "predicate": "sensitivity",
    "description": "Treatment of relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL) in adult and pediatric patients 1 year and older",
    "geneContextQualifier": "CD22",
    "objectTherapeutic": "Inotuzumab ozogamicin [Besponsa]"
}